专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2004014363A1 3,6-DISUBSTITUTED AZABICYCLO [3.1.0] HEXANE DERIVATIVES USEFUL AS MUSCARINIC RECEPTOR ANTAGONIST 审中-公开
标题翻译： 3,6-取代的AZABICYCLO [3.1.0]作为MUSCARINIC受体拮抗剂有效的HEXANE衍生物
公开(公告)号：WO2004014363A1
公开(公告)日：2004-02-19
申请号：PCT/IB2002/003167
申请日：2002-08-09
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , SILAMKOTI, Arundutt, V. , BRUHASPATHY, Miriyala , GUPTA, Jang Bahadur
发明人： MEHTA, Anita , SILAMKOTI, Arundutt, V. , BRUHASPATHY, Miriyala , GUPTA, Jang Bahadur
IPC分类号： A61K31/40
CPC分类号： C07D209/02 , C07D209/52
摘要： This invention generally relates to the derivatives of 3,6 disubstituted azabicyclo[3.1.0] hexanes. The compounds of this invention are muscarinic receptor antagonists which are useful, inter-alia, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.The invention also relates to a process for the preparation of the compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
摘要翻译：本发明一般涉及3,6-二取代的氮杂双环[3.1.0]己烷的衍生物。本发明的化合物是毒蕈碱受体拮抗剂，其特别用于治疗通过毒蕈碱受体介导的呼吸，尿和胃肠道系统的各种疾病。本发明还涉及一种制备本发明包含本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

2. 发明申请

WO2004014853A1 3,6-DISUBSTITUTED AZABICYCLO [3.1.0]HEXANE DERIVATIVES USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译： 3,6-取代的AZABICYCLO [3.1.0]有用的作为MUSCARINIC受体拮抗剂的HEXANE衍生物
公开(公告)号：WO2004014853A1
公开(公告)日：2004-02-19
申请号：PCT/IB2002/002984
申请日：2002-07-31
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , SILAMKOTI, Arundutt, V. , KAUR, Kirandeep , GUPTA, Jang Bahadur
发明人： MEHTA, Anita , SILAMKOTI, Arundutt, V. , KAUR, Kirandeep , GUPTA, Jang Bahadur
IPC分类号： C07D209/02
CPC分类号： C07D209/52
摘要： This invention generally relates to the derivatives of 3,6 disubstituted azabicyclo[3.1.0]hexanes. The compounds of this invention are muscarinic receptor antagonists which are useful, inter-alia, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
摘要翻译：本发明一般涉及3,6-二取代的氮杂双环[3.1.0]己烷的衍生物。本发明的化合物是毒蕈碱受体拮抗剂，其特别用于治疗通过毒蕈碱受体介导的呼吸，尿和胃肠道系统的各种疾病。本发明还涉及制备本发明化合物的方法，含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

3. 发明申请

WO2004004629A2 3,6-DISUBSTITUTED AZABICYCLO [3.1.0]HEXANE DERIVATIVES USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译： 3,6-取代的AZABICYCLO [3.1.0]作为MUSCARINIC受体拮抗剂有效的HEXANE衍生物
公开(公告)号：WO2004004629A2
公开(公告)日：2004-01-15
申请号：PCT/IB2002/002663
申请日：2002-07-08
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , SILAMKOTI, Arundutt, V. , GUPTA, Jang, Bahadur
发明人： MEHTA, Anita , SILAMKOTI, Arundutt, V. , GUPTA, Jang, Bahadur
IPC分类号： A61K
CPC分类号： C07D401/12 , C07D209/52 , C07D403/12 , C07D413/12 , C07D417/12
摘要： This invention generally relates to the derivatives of novel 3,6 disubstituted azabicyclo[3.1.0] hexanes. The compounds of this invention are muscarinic receptor antagonists which are useful, inter-alia for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
摘要翻译：本发明一般涉及新的3,6-二取代的氮杂双环[3.1.0]己烷的衍生物。本发明的化合物是毒蕈碱受体拮抗剂，其特别用于治疗通过毒蕈碱受体介导的呼吸，泌尿和胃肠系统的各种疾病。本发明还涉及含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

4. 发明申请

WO2004067510A1 3,6-DISUBSTITUTED AZABICYCLO HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译： 3,6-取代的亚氨基胆碱衍生物作为MUSCARINIC受体拮抗剂
公开(公告)号：WO2004067510A1
公开(公告)日：2004-08-12
申请号：PCT/IB2003/000256
申请日：2003-01-28
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , SILAMKOTI, Arundutt, V. , KUMAR, Naresh , GUPTA, Jang, Bahadur
发明人： MEHTA, Anita , SILAMKOTI, Arundutt, V. , KUMAR, Naresh , GUPTA, Jang, Bahadur
IPC分类号： C07D209/52
CPC分类号： C07D401/04 , C07D209/52 , C07D401/06 , C07D403/04 , C07D405/04 , C07D405/06 , C07D409/04
摘要： This invention generally relates to derivatives of 3,6 disubstituted azabicyclo hexanes.The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
摘要翻译：本发明一般涉及3,6-二取代的氮杂双环己烷的衍生物。本发明化合物可用作毒蕈碱受体拮抗剂，可用于治疗通过毒蕈碱受体介导的呼吸，泌尿和胃肠系统的各种疾病。本发明还涉及含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

5. 发明申请

WO2004089898A1 SUBSTITUTED AZABICYCLO HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译：作为MUSCARINIC受体拮抗剂的替代的异丁肾上腺素衍生物
公开(公告)号：WO2004089898A1
公开(公告)日：2004-10-21
申请号：PCT/IB2003/001288
申请日：2003-04-09
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , MIRIYALA, Bruhaspathy , ARORA, Sudershan, Kumar , GUPTA, Jang, Bahadur
发明人： MEHTA, Anita , MIRIYALA, Bruhaspathy , ARORA, Sudershan, Kumar , GUPTA, Jang, Bahadur
IPC分类号： C07D209/52
CPC分类号： C07D209/52
摘要： This invention relates to the derivatives of substituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of the compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
摘要翻译：本发明涉及取代的氮杂双环己烷的衍生物。本发明的化合物可用作毒蕈碱受体拮抗剂，可用于治疗通过毒蕈碱受体介导的呼吸，尿和胃肠道系统的各种疾病。本发明还涉及制备本发明化合物的方法，含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

6. 发明申请

WO2004056810A1 XANTHINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译： XANTHINE DERIVATIVES as MUSCARINIC RECEPTOR ANTAGONISTS
公开(公告)号：WO2004056810A1
公开(公告)日：2004-07-08
申请号：PCT/IB2002/005589
申请日：2002-12-23
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , SRIVASTAVA, Sanjay, Kumar , GUPTA, Jang, Bahadur
发明人： MEHTA, Anita , SRIVASTAVA, Sanjay, Kumar , GUPTA, Jang, Bahadur
IPC分类号： C07D405/12
CPC分类号： C07D405/12 , A61K31/40
摘要： This invention generally relates to the derivatives of 3,6 disubstituted azabicyclo[3.1.0] hexanes. The compounds of this invention can function as muscarinic receptor antagonists, inter alia for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of the compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
摘要翻译：本发明一般涉及3,6-二取代的氮杂双环[3.1.0]己烷的衍生物。本发明的化合物可用作毒蕈碱受体拮抗剂，特别是用于治疗通过毒蕈碱受体介导的呼吸，尿和胃肠系统的各种疾病。本发明还涉及制备本发明化合物的方法，含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

7. 发明申请

WO2004069835A1 SUBSTITUTED AZABICYCLO HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译：作为MUSCARINIC受体拮抗剂的替代的异丁肾上腺素衍生物
公开(公告)号：WO2004069835A1
公开(公告)日：2004-08-19
申请号：PCT/IB2003/000416
申请日：2003-02-07
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , MIRIYALA, Bruhaspathy , KUMAR, Naresh , GUPTA, Jang, Bahadur
发明人： MEHTA, Anita , MIRIYALA, Bruhaspathy , KUMAR, Naresh , GUPTA, Jang, Bahadur
IPC分类号： C07D471/08
CPC分类号： C07D471/08
摘要： This invention relates to derivatives of substituted azabicyclo hexanes.The compound of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.The invention also relates to a process for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
摘要翻译：本发明涉及取代的氮杂二环己烷的衍生物。本发明化合物可用作毒蕈碱受体拮抗剂，可用于治疗通过毒蕈碱受体介导的呼吸，泌尿和胃肠系统的各种疾病。本发明还涉及制备本发明化合物的方法，含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

8. 发明申请

WO2004052857A1 3,6-DISUBSTITUTED AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译： 3,6-取代的AZABICYCLO [3.1.0]作为MUSCARINIC受体拮抗剂的HEXANE衍生物
公开(公告)号：WO2004052857A1
公开(公告)日：2004-06-24
申请号：PCT/IB2002/005220
申请日：2002-12-10
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , SILAMKOTI, Arundutt, Viswanatham , MIRIYALA, Bruhaspathy , ARORA, Sudershan, Kumar , SRINIVASULU, Boju , MUKHERJEE, Bireshwar , GUPTA, Jang, Bahadur
发明人： MEHTA, Anita , SILAMKOTI, Arundutt, Viswanatham , MIRIYALA, Bruhaspathy , ARORA, Sudershan, Kumar , SRINIVASULU, Boju , MUKHERJEE, Bireshwar , GUPTA, Jang, Bahadur
IPC分类号： C07D209/52
CPC分类号： C07D401/06 , C07D209/52 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/14
摘要： The invention relates to derivatives of 3,6-disubstituted azabicyclo [3.1.0] hexanes of structure (I). The compounds of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
摘要翻译：本发明涉及结构（I）的3,6-二取代的氮杂双环[3.1.0]己烷的衍生物。本发明化合物可用作毒蕈碱受体拮抗剂，可用于治疗通过毒蕈碱受体介导的呼吸道，尿路和胃肠道系统的各种疾病。本发明还涉及含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。

9. 发明申请

WO2004018422A1 FLUORO AND SULPHONYLAMINO CONTAINING 3,6-DISUBSTITUTED AZABICYCLO (3.1.0) HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译：含有3,6-取代的十八烷基胆碱（3.1.0）的异氟醚和磺酰胺作为MUSCARINIC受体拮抗剂的HEXANE衍生物
公开(公告)号：WO2004018422A1
公开(公告)日：2004-03-04
申请号：PCT/IB2002/003433
申请日：2002-08-23
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , GUPTA, Jang Bahadur
发明人： MEHTA, Anita , GUPTA, Jang Bahadur
IPC分类号： C07D209/52
CPC分类号： C07D209/94 , C07D209/52
摘要： This invention generally relates to the derivatives of novel 3,6 disubstituted azabicyclo[3.1.0] hexane's. The compounds of this invention are MUSCARINIC receptor antagonists which are useful, inter-ail for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through MUSCARINIC receptors. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through MUSCARINIC receptors.
摘要翻译：本发明一般涉及新的3,6-二取代的氮杂双环[3.1.0]己烷的衍生物。本发明的化合物是MUSCARINIC受体拮抗剂，其可用于治疗通过MUSCARINIC受体介导的呼吸，尿和胃肠系统的各种疾病。本发明还涉及制备本发明化合物的方法，含有本发明化合物的药物组合物和通过MUSCARINIC受体介导的疾病的治疗方法。

10. 发明申请

WO2004089899A1 SUBSTITUTED AZABICYCLO HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译：作为MUSCARINIC受体拮抗剂的替代的异丁肾上腺素衍生物
公开(公告)号：WO2004089899A1
公开(公告)日：2004-10-21
申请号：PCT/IB2003/001327
申请日：2003-04-10
申请人： RANBAXY LABORATORIES LIMITED , MEHTA, Anita , MIRIYALA, Bruhaspathy , ARUNDUTT, Silamkoti, Viswanatham , GUPTA, Jang, Bahadur
发明人： MEHTA, Anita , MIRIYALA, Bruhaspathy , ARUNDUTT, Silamkoti, Viswanatham , GUPTA, Jang, Bahadur
IPC分类号： C07D209/52
CPC分类号： C07D209/52
摘要： The present invention relates to a radio telephony network (1) supporting at least one link of a radio channel (6) for a packet data transmission service. The radio telephony network (1) comprises a plurality of network controllers (RNC). Each network controller (RNC) is connected, via an interface Iub, to at least one base radio station (B-node) supervising at least one macrocell (5a). The radio telephony network (1) additionally comprises at least one base radio microstation (Bl-micronode) connected to the network controller (RNC) via an interface Iub of the same type as that connecting the base radio station (B-node) to said controller. The base radio microstation (B1micronode) supervises at least one microcell (5b) incorporated in at least one macrocell (5a). The base radio microstation (B1-micronode) provides the packet data transmission service in the microcell (5b) on the link of the radio channel (6).
摘要翻译：本发明涉及支持用于分组数据传输服务的无线电信道（6）的至少一个链路的无线电电话网络（1）。无线电电话网络（1）包括多个网络控制器（RNC）。每个网络控制器（RNC）经由接口Iub连接到监督至少一个宏小区（5a）的至少一个基站无线电台（B节点）。无线电电话网络（1）还包括经由与将基站无线电台（B节点）连接到所述网络控制器（RNC）的相同类型的接口Iub连接到网络控制器（RNC）的至少一个基站无线电微站（B1-微型站）控制器。基站无线电微站（B1mronode）监督并入至少一个宏小区（5a）中的至少一个微小区（5b）。基站无线电微站（B1-micronode）在无线电信道（6）的链路上的微小区（5b）中提供分组数据传输服务。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式